The structure of coxsackievirus B3 at 3.5 å resolution

Structure

Volumn 3, Issue 7, 1995, Pages 653-667

  Muckelbauer, Jodi K ^a   Kremer, Marcia ^a   Minor, Iwona ^a   Diana, Guy ^b   Dutko, Frank J ^c   Groarke, James ^b   Pevear, Daniel C ^b   Rossmann, Michael G ^a  

^a PURDUE UNIVERSITY   (United States)

^b Guy Diana James Groarke and Daniel C Pevear ViroPharma Inc 1250 S Collegeville Road Collegeville PA 19426 USA ^*  (United States)

^c EASTMAN KODAK COMPANY   (United States)

Author keywords

coxsackievirus B3; enterovirus; viral myocarditis

Indexed keywords

MYRISTIC ACID; MYRISTIC ACID DERIVATIVE; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; COXSACKIE VIRUS INFECTION; ENTEROVIRUS; HUMAN; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PICORNAVIRUS; PROTEIN SECONDARY STRUCTURE; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS CAPSID; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CAPSID; CONSERVED SEQUENCE; COXSACKIEVIRUS INFECTIONS; CRYSTALLOGRAPHY, X-RAY; ENTEROVIRUS B, HUMAN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYRISTIC ACID; MYRISTIC ACIDS; PICORNAVIRIDAE; PROTEIN STRUCTURE, SECONDARY; RNA, VIRAL; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0029645145     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(01)00201-5     Document Type: Article

References (78)

1. Picornaviridae and their replication
2. Physical principles in the construction of regular viruses
3. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses
4. Sequence alignments of picornaviral capsid proteins
5. Structure of a human common cold virus and functional relationship to other picornaviruses
6. Three-dimensional structure of poliovirus at 2.9 å resolution
7. The atomic structure of Mengo virus at 3.0 å resolution
8. The three-dimensional structure of foot-and-mouth disease virus at 2.9 å resolution
9. The major human rhinovirus receptor is ICAM-1
10. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses
11. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells
12. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily
13. Members of the low density lipoprotein receptor family mediate cell entry of a minor group common cold virus
14. Identification of the integrin VLA-2 as a receptor for echovirus 1
15. Decay-accelerating factor (CD55) a glycosyl-phosphatidylinositol-anchored complement regulatory protein is a receptor for several echoviruses
16. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method
17. Structure of a human rhinovirus complexed with its receptor molecule
18. The canyon hypothesis
19. Conservation of the putative receptor attachment site in picornaviruses
20. Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance
21. Evidence for the direct involvement of the rhinovirus canyon in receptor binding
22. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor
23. Purification of a HeLa cell receptor protein for the group B coxsackieviruses
24. Identification of a second cellular receptor for a coxsackievirus B3 variant, CVB3-RD
25. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
26. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells
27. Unrelated animal viruses share receptors
28. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 å resolution
29. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14
30. The prevention of rhinovirus and poliovirus uncoating by WIN 51711: a new antiviral drug
31. Conformational changes in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors
32. Escape mutant analysis of a drug-binding site can be used to map functions in the rhinovirus capsid
33. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating
34. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses
35. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A
36. The structure of human rhinovirus 16
37. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design
38. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus
39. The crystal structure of human rhinovirus serotype 1A (HRV1A)
40. Anatomy and evolution of proteins displaying the viral capsid jellyroll topology
41. Proteolytic cleavage of VP1 in ‘A’ particles of coxsackievirus B3 does not appear to mediate virus uncoating by HeLa cells
42. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding
43. Identification of a single amino acid residue in the capsid protein VP1 of coxsackie-virus B4 that determines the virulent phenotype
44. Evidence for at least two dominant neutralization antigens on human rhinovirus 14
45. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14
46. Antigenic structure of polioviruses of serotypes 1 2 and 3
47. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
48. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera
49. Poliovirus host range is determined by a short amino acid sequence in neutralizing antigenic site 1
50. Implications of the picornavirus capsid structure for polyprotein processing
51. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2
52. Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome
53. Capsid assembly in a family of animal viruses primes an autoproteolytic maturation that depends on a single aspartic acid residue
54. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 å resolution
55. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3
56. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 å
57. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
58. Myristylation of picornavirus capsid protein VP4 and its structural significance
59. Myristate–protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions
60. Acid-induced structural changes in human rhinovirus 14: possible role in uncoating
61. Atomic structure of single-stranded DNA bacteriophage φX174 and its functional implications
62. Calcium ion-induced structural changes in bacteriophage φX174
63. Mechanism of adsorption and eclipse of bacteriophage φX174. II. Attachment and eclipse with isolated Escherichia coli cell wall lipopolysaccharide
64. Electron microscopic studies of bacteriophage φX174 intact and ‘eclipsing’ particles, and the genome by the staining and shadowing method
65. Ion channels in icosahedral virus: a comparative analysis of the structures and binding sites at their fivefold axes
66. Conformational changes in poliovirus assembly and cell entry
67. Structure of a major immunogenic site on foot-and-mouth disease virus
68. Infection of mouse fibroblasts by cardioviruses: premature uncoating and its prevention by elevated pH and magnesium chloride
69. Structure of influenza haemagglutinin at the pH of membrane fusion
70. Acta Crystallogr. D
71. Exploring structural homology of proteins
72. Modelling of the tertiary structure of CVB3 from the structure of poliovirus and rhinovirus
73. Genome of coxsackievirus B3
74. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice
75. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA syntheses
76. Coxsackievirus B3 from an infectious cDNA is cardiovirulent in mice
77. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses
78. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons